Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47,601,550
-
Total 13F shares
-
37,197,195
-
Share change
-
-830,926
-
Total reported value
-
$229,891,130
-
Price per share
-
$6.18
-
Number of holders
-
66
-
Value change
-
-$37,768,183
-
Number of buys
-
37
-
Number of sells
-
23
Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q1 2022
As of 31 Mar 2022,
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,197,195 shares.
The largest 10 holders included
Bellevue Group AG, Soleus Capital Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, BVF INC/IL, JANUS HENDERSON GROUP PLC, RTW INVESTMENTS, LP, Avidity Partners Management LP, Blackstone Inc., MORGAN STANLEY, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
66
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.